Tag Archive for: biotechnology

Gadeta Appoints Scientific Advisory Board and Provides Business Update

/in

Utrecht, Netherlands and Boston, Mass., 20 October 2022: Gadeta B.V. (‘Gadeta’), an innovative clinical-stage biopharmaceutical company pioneering the development of gamma delta (γδ) T-cell receptor (TCR)-based immunotherapies for solid tumors, today announced the formation of a Scientific Advisory Board comprised of internationally renowned leaders in oncology, T cell biology and strategic drug development. The Scientific […]

Read more

AMSilk Relocate Offices to Support Expansion Plans

/in

The purpose-built offices will support its production of game-changing material solutions on an industrial scale Expanding biotech laboratory, pilot plants and office space, AMSilk embarks on the next stage of its journey to provide biofabricated silk materials across the world Munich, Germany, 10 October 2022 – AMSilk GmbH (“AMSilk”), a world leader in supplying innovative high-performance […]

Read more

ImaginAb and Roche have entered a clinical trial supply agreement for provision of atezolizumab (Tecentriq®)1 to Non-Small Cell Lung Cancer Patients Enrolled in ImaginAb’s iPREDICT Phase IIb Study

/in

Los Angeles, California, USA, June 8th, 2022 – ImaginAb Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce that Roche has agreed to provide US approved atezolizumab (Tecentriq®)1, to Non-Small Cell Lung Cancer (NSCLC) patients who are enrolled in ImaginAb’s new Phase IIb […]

Read more

A Q&A with ‘Rising Leader’ Therese Liechtenstein

/in

Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.

Read more

TargED raises €39 million in a series A investment round

/in

TargED is extremely pleased and proud to have raised €39 million in a Series A investment round! Together with an international investor syndicate  we’ll pursue our common goal: to bring Microlyse into clinical development! Read press release

Read more